SCHEMBL7184895

SCHEMBL7184895

CCCOc1c(C(C)(C)CC)cc(C(C)(C)CC)c(OCOC(=O)C(C)(C)C)c1C=CC(=O)c1ccc(OCOC(=O)C(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.43
CYP1A1 P04798 3/20 0.43
CYP1B1 Q16678 3/20 0.43
DPP4 P27487 3/20 0.41
PPARA Q07869 1/20 0.39
PTPN1 P18031 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOB P27338 5/20 0.36
MAOA P21397 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184887 1.00 ABCG2 (0.43) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL9271555 0.97 ABCG2 (0.41) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL7191980 0.92 ABCG2 (0.45) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL7191984 0.92 ABCG2 (0.45) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL7181437 0.92 MAOB (0.43) ABCG2CYP1A1CYP1B1DPP4KDM4E
SCHEMBL7181427 0.92 MAOB (0.43) ABCG2CYP1A1CYP1B1DPP4KDM4E
SCHEMBL7184805 0.91 LMNA (0.44) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL7184816 0.91 LMNA (0.44) ABCG2CYP1A1CYP1B1DPP4PPARA
SCHEMBL7179062 0.89 MAOB (0.37) ABCG2CYP1A1CYP1B1PPARAKDM4E
SCHEMBL7179059 0.89 MAOB (0.37) ABCG2CYP1A1CYP1B1PPARAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed